NM_000251.3:c.1828C>T

Variant names:

• chr2-47475093-C-T
• rs267607980
• NM_000251.3:c.1828C>T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1 PM5 BP4 BP6

The NM_000251.3(MSH2):​c.1828C>T​(p.His610Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H610Q) has been classified as Likely benign.

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 0.0000055 (0 hom.)
• Consequence: MSH2 NM_000251.3 missense
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5 B:2
• Conservation: PhyloP100: 1.38
• Publications: 5 publications found

Genes affected

MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

MSH2 Gene-Disease associations (from GenCC):

• Lynch syndrome

  Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
• Lynch syndrome 1

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
• Muir-Torre syndrome

  Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
• mismatch repair cancer syndrome 1

  Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
• mismatch repair cancer syndrome 2

  Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
• ovarian cancer

  Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
• malignant pancreatic neoplasm

  Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
• prostate cancer

  Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
• rhabdomyosarcoma

  Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
• breast cancer

  Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
• hereditary breast carcinoma

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

• PM1: In a hotspot region, there are 10 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 26 benign, 30 uncertain in NM_000251.3
• PM5: Other missense variant is known to change same aminoacid residue: Variant chr2-47475094-A-C is described in CliVar as Likely_pathogenic. Clinvar id is 1780893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BP4: Computational evidence support a benign effect (MetaRNN=0.331011).
• BP6: Variant 2-47475093-C-T is Benign according to our data. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308. Variant chr2-47475093-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 184308.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MSH2	NM_000251.3	c.1828C>T	p.His610Tyr	missense_variant	Exon 12 of 16	ENST00000233146.7	NP_000242.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MSH2	ENST00000233146.7	c.1828C>T	p.His610Tyr	missense_variant	Exon 12 of 16	1	NM_000251.3	ENSP00000233146.2

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome AF: 0.00000547 AC: 8 AN: 1461834 Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2 AN XY: 727220

African (AFR) AF: 0.00 AC: 0 AN: 33480

American (AMR) AF: 0.00 AC: 0 AN: 44724

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 26134

East Asian (EAS) AF: 0.00 AC: 0 AN: 39690

South Asian (SAS) AF: 0.00 AC: 0 AN: 86242

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53416

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5768

European-Non Finnish (NFE) AF: 0.00000719 AC: 8 AN: 1111986

Other (OTH) AF: 0.00 AC: 0 AN: 60394

GnomAD4 genome Cov.: 32

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:5 Benign:2

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1 Benign:1

Jun 29, 2022

Ambry Genetics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nov 09, 2023

Color Diagnostics, LLC DBA Color Health

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This missense variant replaces histidine with tyrosine at codon 610 of the MSH2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). This variant does not impact MSH2 function in a 6-thioguanine sensitivity assay in haploid human cells (internally defined LOF score threshold <= -1.32, PMID: 33357406). To our knowledge, this variant has not been reported in individuals affected with MSH2-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant affecting the same codon, c.1829A>C (p.His610Pro), is considered to be disease-causing (ClinVar variation ID: 1780893), suggesting that this position may be important for the protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

not specified Uncertain:1

Nov 18, 2016

Genetic Services Laboratory, University of Chicago

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Lynch syndrome 1 Uncertain:1

Oct 04, 2023

Baylor Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Lynch syndrome Uncertain:1

Dec 13, 2023

All of Us Research Program, National Institutes of Health

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This missense variant replaces histidine with tyrosine at codon 610 of the MSH2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). This variant does not impact MSH2 function in a 6-thioguanine sensitivity assay in haploid human cells (internally defined LOF score threshold <= -1.32, PMID: 33357406). To our knowledge, this variant has not been reported in individuals affected with MSH2-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different variant affecting the same codon, c.1829A>C (p.His610Pro), is considered to be disease-causing (ClinVar variation ID: 1780893), suggesting that this position may be important for the protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

not provided Uncertain:1

Dec 31, 2024

GeneDx

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate no damaging effect: exhibits sensitivity to 6-TG and mismatch repair (MMR) function similar to wild-type (PMID: 33357406); This variant is associated with the following publications: (PMID: 18822302, 9774676, 21120944, 36550560, 33357406, 33850299) -

Hereditary nonpolyposis colorectal neoplasms Benign:1

Oct 27, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.089
BayesDel_addAF	Uncertain	0.11	D
BayesDel_noAF	Benign	-0.090
CADD	Benign	17
DANN	Uncertain	0.99
DEOGEN2	Uncertain	0.73	D;.;.;.
Eigen	Benign	-0.21
Eigen_PC	Benign	-0.065
FATHMM_MKL	Uncertain	0.84	D
LIST_S2	Benign	0.85	T;D;T;T
M_CAP	Benign	0.037	D
MetaRNN	Benign	0.33	T;T;T;T
MetaSVM	Uncertain	-0.23	T
MutationAssessor	Benign	1.9	L;.;.;.
PhyloP100		1.4
PrimateAI	Uncertain	0.61	T
PROVEAN	Uncertain	-2.6	D;D;.;D
REVEL	Uncertain	0.43
Sift	Benign	0.17	T;T;.;T
Sift4G	Benign	1.0	T;T;.;T
Polyphen		0.0010	B;.;.;B
Vest4		0.48
MutPred		0.55		Gain of phosphorylation at H610 (P = 0.0926);.;Gain of phosphorylation at H610 (P = 0.0926);Gain of phosphorylation at H610 (P = 0.0926);
MVP		0.91
MPC		0.0064
ClinPred		0.38	T
GERP RS		3.8
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.7
Varity_R		0.30
gMVP		0.69
Mutation Taster		=83/17	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs267607980; hg19: chr2-47702232; COSMIC: COSV51882466; COSMIC: COSV51882466;